Voluntary running-wheel activity, arterial blood gases, and thermal antinociception in rats after 3 buprenorphine formulations

Journal of the American Association for Laboratory Animal Science

Volumn 55, Issue 3, 2016, Pages 306-311

  Johnson, Rebecca A ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BICARBONATE; BUPRENORPHINE; CARBON DIOXIDE; EXTENDED RELEASE BUPRENORPHINE; MU OPIATE RECEPTOR AGONIST; SODIUM CHLORIDE; SUSTAINED RELEASE BUPRENORPHINE; UNCLASSIFIED DRUG; NARCOTIC ANALGESIC AGENT;

ADULT; ANALGESIA; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTERIAL GAS; ARTERIAL OXYGEN TENSION; ARTERIAL PH; ARTICLE; BICARBONATE BLOOD LEVEL; CARBON DIOXIDE BLOOD LEVEL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG FORMULATION; DRUG SCREENING; EXTENDED RELEASE FORMULATION; HYPOXEMIA; LATENT PERIOD; MALE; NONHUMAN; PAIN THRESHOLD; RAT; SINGLE DRUG DOSE; SUSTAINED RELEASE FORMULATION; THERMAL STIMULATION; TREADMILL EXERCISE; WITHDRAWAL REFLEX; ANIMAL; BLOOD GAS ANALYSIS; PAIN; PAIN MEASUREMENT; PHYSIOLOGIC MONITORING; RUNNING; VETERINARY;

ANALGESIA; ANALGESICS, OPIOID; ANIMALS; BLOOD GAS ANALYSIS; BUPRENORPHINE; CROSS-OVER STUDIES; MALE; MONITORING, PHYSIOLOGIC; PAIN; PAIN MEASUREMENT; RATS; RUNNING;

EID: 84968912289     PISSN: 15596109     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Animalgesic Labs. [Internet]. 2015. Studies-Animalgesics. [Cited 06 August 2015] Available at: www.animalgesiclabs.com
2. Bourque SL, Adams MA, Nakatsu K, Winterborn A. 2010. Comparison of buprenorphine and meloxicam for postsurgical analgesia in rats: effects on body weight, locomotor activity, and hemodynamic parameters. J Am Assoc Lab Anim Sci 49:617-622.
3. Brun-Pascaud M, Gaudebout C, Blayo MC, Pocidalo JJ. 1982. Arterial blood gases and acid-base status in awake rats. Respir Physiol 48:45-57.
4. Christoph T, Kögel B, Schiene K, Méen M, De Vry J, Friderichs E. 2005. Broad analgesic profile of buprenorphine in rodent models of acute and chronic pain. Eur J Pharmacol 507:87-98.
5. Chum HH, Jampachairsri K, McKeon GP, Yeomans DC, Pacharinsak C, Felt SA. 2014. Antinociceptive effects of sustained-release buprenorphine in a model of incisional pain in rats (Rattus norvegicus). J Am Assoc Lab Anim Sci 53:193-197.
6. Cooper DM, Hoffman W, Wheat N, Lee HY. 2005. Duration of effects on clinical parameters and referred hyperalgesia in rats after abdominal surgery and multiple doses of analgesia. Comp Med 55:344-353.
7. Cowan A, Doxey JC, Harry EJ. 1977. The animal pharmacology of buprenorphine, an oripavine analgesic agent. Br J Pharmacol 60:547-554.
8. Cowan A, Lewis JW, Macfarlane IR. 1977. Agonist and antagonist properties of buprenorphine, a new antinociceptive agent. Br J Pharmacol 60:537-545.
9. Dahan A, Yassen A, Bijl H, Romberg R, Sarton E, Teppema L, Olofsen E, Danhof M. 2005. Comparison of the respiratory effects of intravenous buprenorphine and fentanyl in humans and rats. Br J Anaesth 94:825-834.
10. Flecknell PA, Liles JH, Wootton R. 1989. Reversal of fentanylfluanisone neuroleptanalgesia in the rabbit using mixed agonist-antagonist opioids. Lab Anim 23:147-155.
11. Foley PL, Liang H, Crichlow AR. 2011. Evaluation of a sustainedrelease formulation of buprenorphine for analgesia in rats. J Am Assoc Lab Anim Sci 50:198-204.
12. Gades NM, Wixson SK, Danneman PJ, Tolley EA. 2001. Inefficacy of buprenorphine in rats. Contemp Top Lab Anim Sci 40:7.
13. Gillingham MB, Clark MD, Dahly EM, Krugner-Higby LA, Ney DM. 2001. A comparison of 2 opioid analgesics for relief of visceral pain induced by intestinal resection in rats. Contemp Top Lab Anim Sci 40:21-26.
14. Gopal S, Tzeng TB, Cowan A. 2002. Characterization of the pharmacokinetics of buprenorphine and norbuprenorphine in rats after intravenous bolus administration of buprenorphine. Eur J Pharm Sci 15:287-293.
15. Guarnieri M, Brayton C, De Tolla L, Forbes-McBean N, Sarabia-Estrada R, Zadnik P. 2012. Safety and efficacy of buprenorphine for analgesia in laboratory mice and rats. Lab Anim (NY) 41:337-343.
16. Gueye PN, Borron SW, Risède P, Monier C, Buneaux F, Debray M, Baud FJ. 2001. Lack of effect of single high doses of buprenorphine on arterial blood gases in the rat. Toxicol Sci 62:148-154.
17. Hargreaves K, Dubner R, Brown F, Flores C, Joris J. 1988. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32:77-88.
18. Institute for Laboratory Animal Research. 2011. Guide for the care and use of laboratory animals, 8th ed. Washington (DC): National Academics Press.
19. Johnson RA, de Morais HA. 2012. Respiratory acid-base disorders, p 287-301. In: Di Bartola SP, editor. Fluid, electrolyte, and acidbase disorders in small animal practice, 4th ed, St. Louis (MO): Saunders.
20. Johnson RA, Mitchell GS. 2003. Exercise-induced changes in hippocampal brain-derived neurotrophic factor and neurotrophin-3: effects of rat strain. Brain Res 983:108-114.
21. Johnson RA, Rhodes JS, Jeffrey SL, Garland T Jr, Mitchell GS. 2003. Hippocampal brain-derived neurotrophic factor but not neurotrophin 3 increases more in mice selected for increased voluntary wheel running. Neuroscience 121:1-7.
22. Le Bars D, Gozariu M, Cadden SW. 2001. Animal models of nociception. Pharmacol Rev 53:597-652.
23. Liles JH, Flecknell PA. 1992. The effects of buprenorphine, nalbuphine, and butorphanol alone or following halothane anaesthesia on food and water consumption and locomotor movement in rats. Lab Anim 26:180-189.
24. Miller AL, Richardson CA. 2011. Rodent analgesia. Vet Clin North Am Exot Anim Pract 14:81-92.
25. Novak CM, Burghardt PR, Levine JA. 2012. The use of a running wheel to measure activity in rodents: relationship to energy balance, general activity, and reward. Neurosci Biobehav Rev 36:1001-1014.
26. Raffa RB, Ding Z. 2007. Examination of the preclinical antinociceptive efficacy of buprenorphine and its designation as full or partial agonist. Acute pain: international journal of acute management 9:145-152.
27. Roughan JV, Flecknell PA. 2000. Effects of surgery and analgesic administration on spontaneous behaviour in singly housed rats. Res Vet Sci 69:283-288.
28. Schaap MW, Uilenreef JJ, Mitsogiannis MD, van't Klooster JG, Arndt SS, Hellebrekers LJ. 2012. Optimizing the dosing interval of buprenorphine in a multimodal postoperative analgesic strategy in the rat: minimizing side-effects without affecting weight gain and food intake. Lab Anim 46:287-292.
29. Schroeder CA, Smith LJ. 2011. Respiratory rates and arterial blood-gas tensions in healthy rabbits given buprenorphine, butorphanol, midazolam, or their combinations. J Am Assoc Lab Anim Sci 50:205-211.
30. Shafford HL, Schadt JC. 2008. Effect of buprenorphine on the cardiovascular and respiratory response to visceral pain in conscious rabbits. Vet Anaesth Analg 35:333-340.
31. Shafford HL, Schadt JC. 2008. Respiratory and cardiovascular effects of buprenorphine in conscious rabbits. Vet Anaesth Analg 35:326-332.